Nuvectis Pharma, Inc. NVCT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -154.4%+33.6pp | -188%-43.0pp | -145%+5.1pp | -150.1%-34.8pp | -115.3%+58.1pp | |
| Liquidity | ||||||
| Current ratio | 2.3×-0.1× | 2.4×-0.7× | 3.1×+0.4× | 2.7×-0.6× | 3.3×+1.2× | |
| Per Share | ||||||
| Book value per share | $0.61-28.1% | $0.84-20.1% | $1.06+33.8% | $0.79-24.9% | $1.05+85.2% | |
| Valuation | ||||||
| Market capitalization | $739.27M+335% | $193.39M+26.2% | $153.25M-8.1% | $166.73M-27.0% | $228.53M+119% | |
| Price / book | 52×+43.9× | 10.5×+4.1× | 6.4×-3.5× | 9.9×-1.0× | 10.9×+0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Nuvectis Pharma, Inc.'s ratios come from?
- Every ratio is computed from Nuvectis Pharma, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.